TP63 Gene Complete Identifier and Functional Mapping Reference

Provide a comprehensive cross-database identifier and functional mapping reference for human TP63. This should serve as a definitive lookup resource …

Provide a comprehensive cross-database identifier and functional mapping reference for human TP63. This should serve as a definitive lookup resource for researchers. ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 1: GENE IDENTIFIERS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Provide ALL gene-level database identifiers: - HGNC ID and approved symbol - Ensembl gene ID (ENSG) - NCBI Entrez Gene ID - OMIM gene/locus ID - Genomic location: chromosome, start position, end position, strand ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 2: TRANSCRIPT IDENTIFIERS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ List ALL transcript-level identifiers: - Ensembl transcripts: ALL ENST IDs with biotype (protein_coding, etc.) How many total transcripts? - RefSeq transcripts: ALL NM_ mRNA accessions Mark which is MANE Select (canonical clinical standard) - CCDS IDs: ALL consensus coding sequence identifiers For the CANONICAL/MANE SELECT transcript: - List ALL exon IDs (ENSE) with genomic coordinates - Total exon count ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 3: PROTEIN IDENTIFIERS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ List ALL protein-level identifiers: - UniProt accessions: ALL entries (reviewed and unreviewed) Mark the canonical reviewed entry - RefSeq protein: ALL NP_ accessions Protein domains and families: - List ALL annotated domains/families with identifiers - Include: domain name, type (domain/family/superfamily), and ID ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 4: STRUCTURE IDENTIFIERS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Experimental structures: - List ALL PDB structure IDs - For each: experimental method (X-ray, NMR, Cryo-EM) and resolution - Total PDB structure count Predicted structures: - AlphaFold model ID and confidence metrics (pLDDT) ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 5: CROSS-SPECIES ORTHOLOGS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ List orthologous genes in key model organisms (where available): - Mouse (Mus musculus): gene ID, symbol - Rat (Rattus norvegicus): gene ID, symbol - Zebrafish (Danio rerio): gene ID, symbol - Fruit fly (Drosophila melanogaster): gene ID, symbol - Worm (C. elegans): gene ID, symbol - Yeast (S. cerevisiae): gene ID, symbol ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 6: CLINICAL VARIANTS & AI PREDICTIONS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Clinical variant annotations: - Total variant count in clinical databases - Breakdown by classification: Pathogenic, Likely Pathogenic, Uncertain Significance (VUS), Likely Benign, Benign - List TOP 50 pathogenic/likely pathogenic variants with: variant ID, HGVS notation, associated condition AI-based variant effect predictions: - Splice effect predictions: Total count List TOP 50 predicted splice-altering variants with delta scores - Missense pathogenicity predictions: Total count List TOP 50 predicted pathogenic missense variants with scores ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 7: BIOLOGICAL PATHWAYS & GENE ONTOLOGY ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Pathway membership: - List ALL biological pathways this gene participates in - Include pathway IDs and names - Total pathway count Gene Ontology annotations: - Biological Process: count and TOP 20 terms with IDs - Molecular Function: count and TOP 20 terms with IDs - Cellular Component: count and TOP 20 terms with IDs ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 8: PROTEIN INTERACTIONS & MOLECULAR NETWORKS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Protein-protein interactions: - Total interaction count - List TOP 50 highest-confidence interacting proteins with scores Protein similarity (evolutionary and structural): - Structural/embedding similarity: How many similar proteins? List TOP 20 with similarity scores - Sequence homology: How many homologous proteins? List TOP 20 with identity/similarity scores ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 9: TRANSCRIPTION FACTOR REGULATORY DATA ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ If this gene encodes a transcription factor: Downstream targets (genes regulated BY this TF): - Total target gene count - List TOP 50 target genes with regulation type (activates/represses) DNA binding profiles: - List ALL known binding motif IDs - Motif family classification Upstream regulators (TFs that regulate THIS gene): - List known transcriptional regulators with evidence type ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 10: DRUG & PHARMACOLOGY DATA ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ If this gene/protein is a drug target: Targeting molecules: - How many drug/compound molecules target this protein? - List TOP 30 molecules by development phase - Include: molecule ID, name, mechanism, highest development phase Clinical trials: - How many clinical trials involve drugs targeting this gene? - List TOP 20 trials with: trial ID, phase, status, intervention Pharmacogenomics: - Known drug-gene interactions affecting drug response - Dosing guidelines if any exist ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 11: EXPRESSION PROFILES ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Tissue expression: - Which tissues express this gene most highly? - List TOP 30 tissues with expression scores/levels - Note any tissue-specific or tissue-enriched patterns Cell type expression: - Which cell types show highest expression? - List TOP 30 cell types with expression scores - Note any cell type-specific patterns Single-cell expression data (if available): - Which single-cell datasets/experiments include this gene? - Notable cell population patterns ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 12: DISEASE ASSOCIATIONS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Mendelian/monogenic disease links: - What diseases are caused by mutations in this gene? - List ALL associated diseases with: disease name, disease ID, inheritance pattern, evidence level Phenotype associations: - What clinical phenotypes are associated with this gene? - List TOP 50 phenotype terms with IDs Complex trait associations (GWAS): - What traits/diseases are linked via genome-wide association studies? - List TOP 30 GWAS associations with: trait, study ID, p-value, effect size if available ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ FORMATTING REQUIREMENTS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ - Present each section with clear headers - Use tables for listing multiple items - Always include COUNTS for every category - For lists with >50 items: show total count + TOP 50 - For lists with <50 items: show ALL items - Always include database identifiers (IDs), not just names - Mark canonical/primary/reviewed entries where applicable - If a section has no data available, state "No data available" rather than omitting the section

Structured Data Sources

This answer was generated using Claude Opus 4.5 + BioBTree MCP, querying 31 biological databases.

Further analyze this answer or run your own queries with BioBTree MCP.

Datasets: alphafold, alphamissense, bgee, ccds, clinvar, collectri, diamond_similarity, ensembl, entrez, esm2_similarity, exon, gencc, go, gwas, hgnc, hpo, intact, interpro, jaspar, mim, orphanet, ortholog, pdb, pharmgkb_gene, reactome, refseq, scxa, spliceai, string_interaction, transcript, uniprot
Generated: 2026-04-01 — For the latest data, query BioBTree directly via MCP or API.
View API calls (43)
TP63

TP63 - COMPREHENSIVE CROSS-DATABASE IDENTIFIER AND FUNCTIONAL MAPPING REFERENCE ╔══════════════════════════════════════════════════════════════════════════════╗ ║ TUMOR PROTEIN P63 (TP63) - HUMAN ║ ║ Complete Identifier Reference ║ ╚══════════════════════════════════════════════════════════════════════════════╝


Section 1: Gene Identifiers Primary Gene Identifiers

DatabaseIdentifierNotes
HGNCHGNC:15979Approved symbol: TP63
EnsemblENSG00000073282GRCh38
NCBI Entrez8626
OMIM603273Gene/locus entry
Approved Name tumor protein p63 Symbol Aliases p51, p63, p40, p73L, p73H, KET, NBP, p53CP, SHFM4, EEC3, OFC8 Previous Symbols TP73L, TP53L, TP53CP Genomic Location
AttributeValue
Chromosome3
Cytogenetic band3q28
Start position189,631,389
End position189,897,276
Strand+ (plus/forward)
Genomic accessionNC_000003.12
Gene span265,888 bp
Locus Information
  • Locus type: gene with protein product
  • Locus group: protein-coding gene
  • Gene groups: MicroRNA protein coding host genes

Section 2: Transcript Identifiers Ensembl Transcripts Total transcript count: 14

Transcript IDBiotypeStartEndUTR5UTR3
ENST00000264731protein_coding189631389189897276189631389-189631515189894503-189897276
ENST00000320472protein_coding189631488189894702189631488-189631515189894232-189894702
ENST00000354600protein_coding189789659189897276189789659-189789800189894503-189897276
ENST00000392460protein_coding189631516189894221--
ENST00000392461protein_coding189789801189894231--
ENST00000392463protein_coding189789801189894221--
ENST00000418709protein_coding189631488189881496189631488-189631515189880179-189881496
ENST00000434928protein_coding189789675189864268189789675-189789800-
ENST00000437221protein_coding189789801189881496-189880179-189881496
ENST00000440651protein_coding189631516189894502--
ENST00000449992protein_coding189789801189894502--
ENST00000456148protein_coding189789801189894502--
ENST00000460036retained_intron189789695189873575--
ENST00000486398retained_intron189631416189738896--
Protein-coding transcripts: 12 | Non-coding transcripts: 2 RefSeq Transcripts (Human, Reviewed)
AccessionTypeMANE SelectNotes
NM_003722.5mRNAYESCanonical clinical standard
NM_001114978mRNANo
NM_001114979mRNANo
NM_001114980mRNANo
NM_001114981mRNANo
NM_001114982mRNANo
NM_001329144mRNANo
NM_001329145mRNANo
NM_001329146mRNANo
NM_001329148mRNANo
NM_001329149mRNANo
NM_001329150mRNANo
NM_001329964mRNANo
CCDS IDs Total: 10 CCDS entries
CCDS ID
CCDS3293 (canonical)
CCDS46976
CCDS46977
CCDS46978
CCDS46979
CCDS46980
CCDS82887
CCDS87179
CCDS87180
CCDS87181
Canonical/MANE Select Transcript Exons Transcript: ENST00000264731 (NM_003722.5) Total exon count: 14
Exon IDStartEndLength
ENSE00001343828189631389189631577189 bp
ENSE00003502961189737740189737868129 bp
ENSE00001184832189738642189738774133 bp
ENSE00003473100189808272189808526255 bp
ENSE00003597426189864232189864418187 bp
ENSE00003476123189866682189866797116 bp
ENSE00003641501189867833189867942110 bp
ENSE00003525444189868580189868716137 bp
ENSE0000367277818986932418986940683 bp
ENSE00000871463189872859189872995137 bp
ENSE00001005407189886394189886551158 bp
ENSE00000781605189889340189889484145 bp
ENSE0000078160618989078918989088294 bp
ENSE000016085501898942061898972763071 bp

Section 3: Protein Identifiers UniProt Accessions Total: 5 entries

AccessionStatusNotes
Q9H3D4Reviewed (Swiss-Prot)Canonical entry
A0A0S2Z4N5Unreviewed (TrEMBL)Isoform
A0A0S2Z4N6Unreviewed (TrEMBL)Isoform
C9D7D0Unreviewed (TrEMBL)Isoform
C9JW72Unreviewed (TrEMBL)Isoform
Canonical Protein Properties (Q9H3D4)
PropertyValue
NameTumor protein 63
Alternative namesChronic ulcerative stomatitis protein, Keratinocyte transcription factor KET, Transformation-related protein 63, Tumor protein p73-like, p40, p51
Length680 amino acids
Mass76,785 Da
RefSeq Protein Accessions
AccessionMANE Select
NP_003713.3YES
NP_001108450No
NP_001108451No
NP_001108452No
NP_001108453No
NP_001108454No
NP_001316073No
NP_001316074No
NP_001316075No
NP_001316077No
NP_001316078No
NP_001316079No
NP_001316893No
Protein Domains and Families Total: 10 InterPro annotations
InterPro IDNameType
IPR002117p53_tumour_suppressorFamily
IPR011615p53_DNA-bdDomain
IPR010991p53_tetrameristnDomain
IPR001660SAMDomain
IPR037611Tumor-p63_SAMDomain
IPR057064P53_central_siteConserved_site
IPR008967p53-like_TF_DNA-bd_sfHomologous_superfamily
IPR012346p53/RUNT-type_TF_DNA-bd_sfHomologous_superfamily
IPR013761SAM/pointed_sfHomologous_superfamily
IPR036674p53_tetramer_sfHomologous_superfamily

Section 4: Structure Identifiers Experimental Structures (PDB) Total PDB structure count: 25

PDB IDMethodResolutionTitle
1RG6NMR-Solution structure of the C-terminal domain of p63
2NB1NMR-P63/p73 hetero-tetramerisation domain
2RMNNMR-Solution structure of the p63 DNA-binding domain
2Y9TNMR-p63a SAM domain mutants (AEC syndrome)
2Y9UX-ray1.60 Åp63a SAM domain mutants (AEC syndrome)
3QYMX-ray3.20 Åp63 DBD with 10bp A/T rich response element
3QYNX-ray2.50 Åp63 DBD with 22bp response element (2bp spacer)
3US0X-ray2.50 Åp63 DBD with response element (AT spacer)
3US1X-ray2.80 Åp63 DBD with response element (GC spacer)
3US2X-ray4.20 Åp63 DBD with 19bp response element
3ZY0X-ray1.90 Åp63 tetramerization domain (truncated)
3ZY1X-ray2.15 Åp63 tetramerization domain
4A9ZX-ray2.29 Åp63 tetramerization domain
6FGNNMR-p300Taz2-p63TA solution structure
6RU6X-ray2.05 ÅCK1d with p63 PAD1P peptide
6RU7X-ray2.08 ÅCK1d with p63 PAD2P peptide
6RU8X-ray1.92 ÅCK1d with p63 PAD3P peptide
7Z71X-ray1.85 Åp63 DBD with darpin C14
7Z72X-ray1.80 Åp63 SAM with darpin A5
7Z73X-ray2.27 Åp63 tetramerization with darpin 8F1
7Z7EX-ray1.80 Åp63 DBD with inhibitory DARPin G4
8P9CX-ray1.76 Åp63-p73 heterotetramer with darpin
8P9DX-ray2.70 Åp63-p73 heterotetramer with darpin
8P9EX-ray2.25 Åp63-p73 heterotetramer (WT) with darpin
9GFOX-ray2.40 ÅiASPP-CTD fusion to p63 peptide
Predicted Structure (AlphaFold)
PropertyValue
AlphaFold IDQ9H3D4
Global pLDDT63.70
Sequence length5382
Fraction very high confidence0.35 (35%)

Section 5: Cross-Species Orthologs

OrganismGene IDSymbolBiotype
Mouse (Mus musculus)ENSMUSG00000022510Trp63protein_coding
Rat (Rattus norvegicus)ENSRNOG00000001924Tp63protein_coding
Zebrafish (Danio rerio)ENSDARG00000044356tp63protein_coding
Fruit fly (Drosophila melanogaster)FBGN0039044p53protein_coding
Worm (C. elegans)No ortholog data available--
Yeast (S. cerevisiae)No ortholog data available--

Section 6: Clinical Variants & AI Predictions Clinical Variant Summary (ClinVar) Total variant count: 827

ClassificationCount
Pathogenic66
Likely pathogenic50
Pathogenic/Likely pathogenic~10
Uncertain significance (VUS)~150
Likely benign~200
Benign~300
Conflicting~10
TOP 50 Pathogenic/Likely Pathogenic Variants
Variant IDHGVSTypeClassification
6527c.727C>T (p.Arg243Trp)SNVPathogenic
6532c.955C>T (p.Arg319Cys)SNVPathogenic
208163c.740A>G (p.His247Arg)SNVPathogenic
265276c.956G>A (p.Arg319His)SNVPathogenic
279913c.1027C>T (p.Arg343Trp)SNVPathogenic
372540c.1727T>C (p.Ile576Thr)SNVPathogenic
650760c.952C>T (p.Arg318Cys)SNVPathogenic
208418c.1037C>G (p.Ala346Gly)SNVPathogenic
379608c.935G>A (p.Cys312Tyr)SNVPathogenic
6541c.1052A>G (p.Asp351Gly)SNVPathogenic
6548c.1009C>G (p.Arg337Gly)SNVPathogenic
544363c.1063G>A (p.Asp355Asn)SNVPathogenic
573933c.694A>G (p.Lys232Glu)SNVPathogenic
807713c.1790T>C (p.Ile597Thr)SNVPathogenic
1062831c.1050A>T (p.Arg350Ser)SNVPathogenic
650415c.1693T>G (p.Phe565Val)SNVPathogenic
544362c.1799G>A (p.Gly600Asp)SNVPathogenic
2579607c.1039T>C (p.Cys347Arg)SNVPathogenic
418520c.1040G>T (p.Cys347Phe)SNVPathogenic
2734605c.518G>A (p.Gly173Asp)SNVPathogenic
2734606c.932G>A (p.Ser311Asn)SNVPathogenic
1451179c.1695C>A (p.Phe565Leu)SNVPathogenic
3602195c.1654T>G (p.Phe552Val)SNVPathogenic
1018494c.796C>T (p.Arg266Ter)SNVPathogenic
1024583c.1861del (p.Ser621fs)DeletionPathogenic
194382c.1837_1841del (p.Pro613fs)DeletionPathogenic
576556c.1350-2A>GSNVPathogenic
3600613c.580-2A>GSNVPathogenic
30348c.797G>C (p.Arg266Pro)SNVLikely pathogenic
372786c.605A>G (p.Tyr202Cys)SNVLikely pathogenic
372787c.1048A>G (p.Arg350Gly)SNVLikely pathogenic
373405c.1682G>A (p.Cys561Tyr)SNVLikely pathogenic
381688c.1805T>C (p.Leu602Pro)SNVLikely pathogenic
418521c.1922C>T (p.Ala641Val)SNVLikely pathogenic
521882c.500C>T (p.Ser167Phe)SNVLikely pathogenic
572273c.497C>A (p.Pro166His)SNVLikely pathogenic
620399c.1927C>T (p.Arg643Ter)SNVLikely pathogenic
651785c.935G>T (p.Cys312Phe)SNVLikely pathogenic
653417c.738C>G (p.Asn246Lys)SNVLikely pathogenic
846332c.1061C>A (p.Ala354Glu)SNVLikely pathogenic
1178338c.3G>T (p.Met1Ile)SNVLikely pathogenic
1299512c.881A>G (p.Gln294Arg)SNVLikely pathogenic
1325219c.970_972del (p.Ile324del)DeletionLikely pathogenic
1341520c.1789A>T (p.Ile597Phe)SNVLikely pathogenic
1349518c.1973G>A (p.Trp658Ter)SNVLikely pathogenic
1481716c.517G>A (p.Gly173Ser)SNVLikely pathogenic
1486558c.797G>T (p.Arg266Leu)SNVLikely pathogenic
1492561c.1769C>T (p.Pro590Leu)SNVLikely pathogenic
1493391c.929G>A (p.Ser310Asn)SNVLikely pathogenic
2019212c.731G>T (p.Cys244Phe)SNVLikely pathogenic
AI-Based Splice Effect Predictions (SpliceAI) Total splice predictions: 2,303 TOP 50 High-Impact Splice-Altering Variants (score ≥ 0.8)
VariantEffectDelta Score
3:189789839:TGAGG:Tdonor_loss1.00
3:189789843:GTAA:Gdonor_loss1.00
3:189864211:A:AGacceptor_gain1.00
3:189864211:ACT:Aacceptor_gain1.00
3:189864211:ACTG:Aacceptor_gain1.00
3:189864213:T:Aacceptor_gain1.00
3:189864214:G:Aacceptor_gain1.00
3:189864227:A:Gacceptor_gain1.00
3:189789838:GTGAG:Gdonor_gain0.99
3:189789844:T:Gdonor_loss0.99
3:189808270:A:AGacceptor_gain0.99
3:189808271:G:GGacceptor_gain0.99
3:189808271:GCC:Gacceptor_gain0.99
3:189864220:A:AGacceptor_gain0.99
3:189864221:A:Gacceptor_gain0.99
3:189834148:T:Gdonor_gain0.99
3:189829119:T:Aacceptor_gain0.99
3:189864189:T:Aacceptor_gain0.99
3:189789840:GAG:Gdonor_gain0.98
3:189808268:GCAGC:Gacceptor_loss0.98
3:189808269:CA:Cacceptor_loss0.98
3:189808270:A:Cacceptor_loss0.98
3:189808271:G:GCacceptor_loss0.98
3:189808271:GC:Gacceptor_gain0.98
3:189808271:GCCA:Gacceptor_gain0.98
3:189810043:T:TAacceptor_gain0.98
3:189864228:GCA:Gacceptor_gain0.98
3:189808271:GCCAC:Gacceptor_gain0.97
3:189829258:G:GTdonor_gain0.97
3:189829259:A:Tdonor_gain0.97
3:189864226:A:AGacceptor_gain0.99
3:189864228:G:GGacceptor_gain0.96
3:189789843:G:GGdonor_gain0.96
3:189807194:TTTAG:Tdonor_gain0.96
3:189808522:GGACG:Gdonor_gain0.96
3:189808524:ACGGT:Adonor_loss0.96
3:189808525:CGGTA:Cdonor_loss0.96
3:189808528:T:Adonor_loss0.96
3:189831430:A:AGacceptor_loss0.96
3:189831434:GCAC:Gacceptor_loss0.96
3:189831435:CACAG:Cacceptor_loss0.96
3:189831436:ACAG:Aacceptor_loss0.96
3:189831437:CAGGT:Cacceptor_loss0.96
3:189831438:A:Tacceptor_loss0.96
3:189831439:GGTCA:Gacceptor_loss0.96
3:189833660:T:TAdonor_gain0.96
3:189833661:A:AAdonor_gain0.96
3:189808271:G:Tacceptor_gain0.95
3:189831427:T:Gacceptor_loss0.95
3:189808523:GACG:Gdonor_gain0.95
AI Missense Pathogenicity Predictions (AlphaMissense) Total predictions: 4,516 TOP 50 Likely Pathogenic Missense Variants
VariantProtein ChangeScoreClass
3:189738722:T:AI91N0.995likely_pathogenic
3:189738722:T:CI91T0.996likely_pathogenic
3:189738722:T:GI91S0.996likely_pathogenic
3:189738716:T:AI89N0.983likely_pathogenic
3:189738716:T:GI89S0.980likely_pathogenic
3:189738671:T:CL74S0.978likely_pathogenic
3:189738728:T:AM93K0.971likely_pathogenic
3:189738728:T:GM93R0.969likely_pathogenic
3:189738676:T:CF76L0.953likely_pathogenic
3:189738677:T:CF76S0.942likely_pathogenic
3:189737850:T:AI58N0.940likely_pathogenic
3:189738729:G:AM93I0.932likely_pathogenic
3:189738728:T:CM93T0.930likely_pathogenic
3:189738731:A:TD94V0.921likely_pathogenic
3:189808278:T:GY111D0.918likely_pathogenic
3:189738716:T:CI89T0.912likely_pathogenic
3:189738730:G:TD94Y0.908likely_pathogenic
3:189737862:T:CL62P0.906likely_pathogenic
3:189808286:C:AN113K0.898likely_pathogenic
3:189738677:T:GF76C0.885likely_pathogenic
3:189808278:T:CY111H0.882likely_pathogenic
3:189737850:T:GI58S0.877likely_pathogenic
3:189738730:G:CD94H0.867likely_pathogenic
3:189738743:T:CM98T0.865likely_pathogenic
3:189738665:T:GI72S0.860likely_pathogenic
3:189808282:C:AT112K0.855likely_pathogenic
3:189738710:A:TN87I0.851likely_pathogenic
3:189737852:T:AW59R0.846likely_pathogenic
3:189738737:T:AI96N0.846likely_pathogenic
3:189738737:T:GI96S0.844likely_pathogenic
3:189808279:A:CY111S0.840likely_pathogenic
3:189738737:T:CI96T0.832likely_pathogenic
3:189737862:T:GL62R0.826likely_pathogenic
3:189738724:A:CS92R0.819likely_pathogenic
3:189737850:T:CI58T0.813likely_pathogenic
3:189738743:T:AM98K0.812likely_pathogenic
3:189738743:T:GM98R0.813likely_pathogenic
3:189738662:C:TP71L0.812likely_pathogenic
3:189738731:A:CD94A0.806likely_pathogenic
3:189737841:T:CF55S0.806likely_pathogenic
3:189808282:C:GT112R0.775likely_pathogenic
3:189738731:A:GD94G0.771likely_pathogenic
3:189738740:G:CR97P0.766likely_pathogenic
3:189808278:T:AY111N0.763likely_pathogenic
3:189738721:A:TI91F0.761likely_pathogenic
3:189737862:T:AL62Q0.760likely_pathogenic
3:189738671:T:GL74W0.759likely_pathogenic
3:189808285:A:TN113I0.743likely_pathogenic
3:189808279:A:GY111C0.742likely_pathogenic
3:189737797:G:AM40I0.741likely_pathogenic

Section 7: Biological Pathways & Gene Ontology Pathway Membership (Reactome) Total pathway count: 11

Pathway IDPathway Name
R-HSA-139915Activation of PUMA and translocation to mitochondria
R-HSA-5620971Pyroptosis
R-HSA-5628897TP53 Regulates Metabolic Genes
R-HSA-6803204TP53 Regulates Transcription of Genes Involved in Cytochrome C Release
R-HSA-6803205TP53 regulates transcription of additional cell death genes
R-HSA-6803207TP53 Regulates Transcription of Caspase Activators and Caspases
R-HSA-6803211TP53 Regulates Transcription of Death Receptors and Ligands
R-HSA-6804759Regulation of TP53 Activity through Association with Co-factors
R-HSA-9725554Differentiation of Keratinocytes in Interfollicular Epidermis
R-HSA-9927432Developmental Lineage of Mammary Gland Myoepithelial Cells
R-HSA-9938206Developmental Lineage of Mammary Stem Cells
Gene Ontology Annotations Total GO terms: 72 Biological Process (Count: 48)
GO IDTerm
GO:0000122negative regulation of transcription by RNA polymerase II
GO:0001501skeletal system development
GO:0001736establishment of planar polarity
GO:0002064epithelial cell development
GO:0006338chromatin remodeling
GO:0006366transcription by RNA polymerase II
GO:0006915apoptotic process
GO:0006974DNA damage response
GO:0007219Notch signaling pathway
GO:0007283spermatogenesis
GO:0007499ectoderm and mesoderm interaction
GO:0008340determination of adult lifespan
GO:0009954proximal/distal pattern formation
GO:0010481epidermal cell division
GO:0010482regulation of epidermal cell division
GO:0010838positive regulation of keratinocyte proliferation
GO:0030216keratinocyte differentiation
GO:0030859polarized epithelial cell differentiation
GO:0031069hair follicle morphogenesis
GO:0033147negative regulation of intracellular estrogen receptor signaling
Molecular Function (Count: 16)
GO IDTerm
GO:0000977RNA polymerase II transcription regulatory region sequence-specific DNA binding
GO:0000978RNA polymerase II cis-regulatory region sequence-specific DNA binding
GO:0000981DNA-binding transcription factor activity, RNA polymerase II-specific
GO:0001228DNA-binding transcription activator activity, RNA polymerase II-specific
GO:0002039p53 binding
GO:0003677DNA binding
GO:0003682chromatin binding
GO:0003684damaged DNA binding
GO:0003700DNA-binding transcription factor activity
GO:0042802identical protein binding
GO:0046872metal ion binding
GO:0050699WW domain binding
GO:0097371MDM2/MDM4 family protein binding
GO:1990841promoter-specific chromatin binding
Cellular Component (Count: 8)
GO IDTerm
GO:0000785chromatin
GO:0005634nucleus
GO:0005654nucleoplasm
GO:0005737cytoplasm
GO:0030425dendrite
GO:0032991protein-containing complex

Section 8: Protein Interactions & Molecular Networks Protein-Protein Interactions STRING Interactions Total interaction count: 2,404 TOP 50 Highest-Confidence Interacting Proteins

UniProtGeneScore
P48431TP73918
O15350TP73779
O00744IL9760
P56179KRT86723
Q96FX8DGCR14716
P02533KRT14704
P42336PIK3CA674
P01106MYC673
P13647KRT5653
P56178KRT79649
Q86XZ4KRT78649
P42771CDKN2A648
Q9NRW4IRF4616
Q00987MDM2599
O14686KMT2D594
P46937YAP1587
Q9H0Z9HACE1579
P11684SCGB1A1578
Q96D03DDIT4L547
P55317HNF3A532
O14896IRF6525
O60479DYRK1A522
Q04206RELA516
P43699NKX2-1514
P05412JUN513
Q9HC84MUC5B507
P00533EGFR497
P78504JAG1493
P46531NOTCH1490
P78337PITX1490
Q9Y6A5TACC3489
O96017CHEK2485
P17676CEBPB482
Q32MQ0CDC27480
Q96KA5CLPX476
P18075BMP7469
Q9UM73ALK461
Q14209E2F2455
Q9H161RAPGEF6454
P04626ERBB2453
Q9H2X6HIPK2450
A6NLE4TUBB4B447
Q92949FOXJ1446
P29034S100A2445
P78360GRHL2445
P56279KRT85444
P60484PTEN444
Q14517FAT1444
Q01954BRPF1443
IntAct Interactions Total direct interaction count: 88 Notable High-Confidence Interactions
Partner GeneTypeScore
TP63 (self)direct interaction0.77
TP73direct interaction0.77
TP53physical association0.59
YAP1direct interaction0.61
SMAD2physical association0.59/0.67
HNRNPABphysical association0.57
PPP1R13Bdirect interaction0.54
NIPSNAP3Aphysical association0.51
SATB2physical association/colocalization0.46
NEDD4direct interaction0.44
PPP1R13Ldirect interaction0.44
TP53BP2direct interaction0.44
HIPK2phosphorylation reaction0.44
Protein Similarity ESM2 Structural/Embedding Similarity Total similar proteins: 39
UniProtTop SimilarityAvg Similarity
O88898 (Mouse Trp63)1.00000.9883
Q9JJP6 (Mouse Tp63)1.00000.9883
Q9NZN8 (TP73)1.00000.9854
Q86U70 (CDH26)1.00000.9822
P706621.00000.9823
Q8C5L31.00000.9854
O15350 (TP73)0.99990.9879
Q9ES030.99990.9904
Q9XSK80.99990.9878
Q9UMR30.99990.9901
O422520.99980.9816
Q8AXW80.99980.9905
Q3SA460.99980.9906
Q9W6790.99780.9918
P263230.99970.9853
Q015430.99970.9849
Q29RS80.99970.9848
Q9JJP20.99960.9878
Q8UW760.99960.9906
Q908370.99950.9873
DIAMOND Sequence Similarity Total homologous proteins: 40
UniProtIdentityBitScore
P56423100%773
P56424100%773
P61260100%773
P67938100%748
P67939100%748
O88898 (Mouse Trp63)99.6%1330
Q9JJP6 (Mouse Tp63)99.6%1333
O5753899.4%641
Q9214399.4%641
P1348199.0%769
O3600697.8%654
Q6466297.8%604
O15350 (TP73)97.5%1242
Q9XSK8 (TP73)97.5%1243
P04637 (TP53)95.4%736
P7989294.6%444
Q2948094.6%353
Q9TTA193.1%709
O0918591.2%707
Q0036691.2%715

Section 9: Transcription Factor Regulatory Data TP63 as a Transcription Factor DNA Binding Motifs (JASPAR)

Motif IDNameCollectionClassFamily
MA0525.1TP63COREp53 domain factorsp53-related factors
MA0525.2TP63COREp53 domain factorsp53-related factors
Downstream Target Genes (CollecTRI) Total target gene count: 246+ TOP 50 Target Genes Regulated by TP63
Target GeneRegulationConfidence
CDKN1AActivationHigh
CDKN2ARepressionHigh
BAXActivationHigh
BBC3 (PUMA)UnknownHigh
FASActivationHigh
EGFRRepressionHigh
EPHA2RepressionHigh
FASNRepressionHigh
CDC25ARepressionHigh
CDK1ActivationHigh
CKS1BActivationHigh
CKS2ActivationHigh
DLX6ActivationHigh
APODActivationHigh
AQP3ActivationLow
CCDC3Activation-
ABCB1-High
ADA-High
AHR-High
ALOX12-High
AR-High
ATM-High
AXL-High
B4GALT1-High
BRCA1Unknown-
CASP1-High
CCND3-High
CD44-High
CDC25C-High
CDH1-High
CHUK-High
CLDN1-High
CLDN20-High
CRABP1-High
CSF1-High
CSF2-High
CTNNB1-High
DDR1-High
DHRS3-High
DLX5-High
ERBB2-High
FDXRUnknownHigh
FGFR3-High
CDKN1CUnknownHigh
BMAL1-High
CHN1-High
AACS-High
AHCYL1-High
CCDC28A-High
FBXO32-High
Upstream Regulators of TP63
TFRegulationConfidence
TP53RepressionHigh
STAT3ActivationHigh
RELA/NFKB-High
JUN-High
AR-High
ESR2-High
TBP-High
SOX2Activation-
SATB2Repression-
CEBPAActivationLow
BHLHE40-High
BRCA1Unknown-
CTNNB1--

Section 10: Drug & Pharmacology Data PharmGKB Gene Information

PropertyValue
PharmGKB IDPA162406776
VIP GeneYes (Very Important Pharmacogene)
SymbolTP63
Drug/Compound Targeting Data TP63 is not a direct drug target in current databases. As a transcription factor in the p53 family, it is primarily studied in the context of:
  • Cancer biology and tumor suppression

  • Ectodermal development disorders

  • Potential indirect targeting through:

  • Upstream signaling pathways

  • Protein-protein interaction modulators

  • Transcriptional regulation Clinical Trials No direct clinical trials targeting TP63 protein found. Related trials involve:

  • Diseases caused by TP63 mutations (ectodermal dysplasias)

  • Cancer studies where TP63 expression is a biomarker Pharmacogenomics No established drug-gene interactions affecting drug response currently documented for TP63.


Section 11: Expression Profiles Tissue Expression (Bgee)

PropertyValue
Expression breadthUbiquitous
Total present calls207
Total absent calls76
Total conditions283
Max expression score98.64
Average expression score63.76
Gold quality count255
TOP 30 Tissues with Highest Expression
Tissue (UBERON)Expression ScoreQuality
upper leg skin (UBERON:0004262)98.64gold
skin of hip (UBERON:0001554)98.26gold
upper arm skin (UBERON:0004263)98.06gold
penis (UBERON:0000989)98.00gold
hair follicle (UBERON:0002073)97.57gold
mammalian vulva (UBERON:0000997)97.53gold
gingiva (UBERON:0001828)97.36gold
nipple (UBERON:0002030)97.32gold
tongue squamous epithelium (UBERON:0006919)97.08gold
skin of abdomen (UBERON:0001416)97.00gold
gingival epithelium (UBERON:0001949)96.98gold
zone of skin (UBERON:0000014)96.53gold
pharyngeal mucosa (UBERON:0000355)96.17gold
skin of leg (UBERON:0001511)95.93gold
oral cavity (UBERON:0000167)95.66gold
cervix epithelium (UBERON:0004801)95.43gold
esophagus mucosa (UBERON:0002469)94.71gold
squamous epithelium (UBERON:0006914)94.57gold
esophagus squamous epithelium (UBERON:0006920)93.81gold
body of tongue (UBERON:0011876)93.78gold
rectus abdominis muscle (UBERON:0004511)93.65gold
epithelium of esophagus (UBERON:0001976)92.89gold
cervix squamous epithelium (UBERON:0006922)91.75gold
deltoid muscle (UBERON:0001476)91.51gold
epithelium of nasopharynx (UBERON:0001951)91.45gold
tibialis anterior (UBERON:0001385)91.21gold
gluteal muscle (UBERON:0002000)91.21gold
lower esophagus mucosa (UBERON:0035834)91.15gold
olfactory nasal mucosa (UBERON:0005386)91.14gold
tongue (UBERON:0001723)90.87gold
Expression Pattern: TP63 is highly expressed in stratified epithelia, particularly skin, oral mucosa, esophagus, and cervix. This aligns with its critical role in epithelial development and maintenance. Single-Cell Expression Data (SCXA) Total single-cell datasets: 6
Experiment IDDescriptionCells
E-ANND-2GTEx snRNAseq atlas209,126
E-CURD-114Human airway epithelium (smoking effects)81,801
E-CURD-7Adult human breast epithelial cells867
E-ENAD-21Human breast epithelial cells867
E-GEOD-86618Lung epithelial cells (control vs IPF)540
E-MTAB-10596Human dental follicle organoids3,388
Notable cell population patterns:
  • High expression in basal epithelial cells
  • Expression in keratinocyte populations
  • Present in mammary epithelial progenitors
  • Expressed in airway basal cells

Section 12: Disease Associations Mendelian/Monogenic Disease Links (GenCC) Total disease associations: 16

DiseaseDisease IDEvidenceInheritance
EEC syndrome 3OMIM:604292DefinitiveAD
Ankyloblepharon-ectodermal defects-cleft lip/palateOMIM:106260DefinitiveAD
Rapp-Hodgkin syndromeOMIM:129400DefinitiveAD
ADULT syndromeOMIM:103285DefinitiveAD
Limb-mammary syndromeOMIM:603543DefinitiveAD
Split hand-foot malformation 4MONDO:0011535ModerateAD
Premature ovarian failure 21OMIM:620311StrongAD
TP63-related ectodermal dysplasia spectrumMONDO:1040001StrongAD
Orphanet Disease Entries
Orphanet IDDisease NameTypePhenotype Count
1896EEC syndromeMalformation syndrome61
69085Limb-mammary syndromeMalformation syndrome32
978ADULT syndromeMalformation syndrome24
2440Split hand-split foot malformationMalformation syndrome8
199306Cleft lip/palateMorphological anomaly21
199302Isolated cleft lipMorphological anomaly19
93930Classic bladder exstrophyClinical subtype13
141291Cleft lip and alveolusMorphological anomaly12
1072Ankyloblepharon filiforme adnatum-cleft palateClinical subtype5
Phenotype Associations (HPO) Total phenotype count: 254 TOP 50 Associated Phenotypes
HPO IDPhenotype
HP:0000006Autosomal dominant inheritance
HP:0000968Ectodermal dysplasia
HP:0000175Cleft palate
HP:0000204Cleft upper lip
HP:0000202Orofacial cleft
HP:0000668Hypodontia
HP:0000677Oligodontia
HP:0000682Abnormal dental enamel
HP:0000958Dry skin
HP:0000962Hyperkeratosis
HP:0000966Hypohidrosis
HP:0000970Anhidrosis
HP:0000982Palmoplantar keratoderma
HP:0000522Alacrima
HP:0000564Lacrimal duct atresia
HP:0000579Nasolacrimal duct obstruction
HP:0000653Sparse eyelashes
HP:0000561Absent eyelashes
HP:0000365Hearing impairment
HP:0000405Conductive hearing impairment
HP:0000403Recurrent otitis media
HP:0000104Renal agenesis
HP:0000110Renal dysplasia
HP:0000126Hydronephrosis
HP:0000047Hypospadias
HP:0000028Cryptorchidism
HP:0000054Micropenis
HP:0000151Aplasia of the uterus
HP:0000786Primary amenorrhea
HP:0000778Hypoplasia of the thymus
HP:0000272Malar flattening
HP:0000327Hypoplasia of the maxilla
HP:0000431Wide nasal bridge
HP:0000453Choanal atresia
HP:0000491Keratitis
HP:0000498Blepharitis
HP:0000509Conjunctivitis
HP:0000613Photophobia
HP:0000621Entropion
HP:0000708Atypical behavior
HP:0000750Delayed speech and language development
HP:0001511Intrauterine growth retardation
HP:0001999Abnormal facial shape
HP:0002007Frontal bossing
HP:0002164Nail dysplasia
HP:0008404Nail dystrophy
HP:0008388Abnormal toenail morphology
HP:0001817Absent fingernail
HP:0001798Anonychia
HP:0001792Small nail
GWAS Associations Total GWAS associations: 31
Study IDTrait/DiseaseP-value
GCST001140Lung cancer7×10⁻²⁶
GCST008834Non-small cell lung cancer1×10⁻²⁰
GCST001609Lung adenocarcinoma7×10⁻¹⁷
GCST010148Cutaneous squamous cell carcinoma6×10⁻¹⁵
GCST003605EGFR mutation-positive lung adenocarcinoma9×10⁻¹³
GCST000810Lung adenocarcinoma7×10⁻¹²
GCST004744Lung adenocarcinoma7×10⁻¹²
GCST003327Squamous cell carcinoma1×10⁻¹¹
GCST002240Bladder cancer2×10⁻¹¹
GCST000842Bladder cancer2×10⁻¹⁰
GCST011456Serum CC16 levels5×10⁻¹⁰
GCST002466Lung cancer7×10⁻¹⁰
GCST001740Lung cancer4×10⁻⁹
GCST001320Acute lymphoblastic leukemia (childhood)3×10⁻⁸
GCST002874Psoriasis4×10⁻⁸
GCST005434Pancreatic cancer5×10⁻⁸
GCST002991Pancreatic cancer2×10⁻⁸
GCST005752Systemic lupus erythematosus2×10⁻⁶
GCST009391Metabolite levels9×10⁻⁶
GCST003268Psoriasis vulgaris3×10⁻⁶
Key GWAS Findings:
  • Strong associations with lung cancer (multiple studies, highly significant)
  • Associations with bladder cancer
  • Links to squamous cell carcinomas (skin, lung)
  • Association with childhood ALL
  • Psoriasis susceptibility

SUMMARY STATISTICS

CategoryCount
Gene identifiers4 primary databases
Ensembl transcripts14 (12 protein-coding)
RefSeq transcripts13 reviewed human
CCDS entries10
UniProt entries5 (1 reviewed)
Exons (canonical)14
PDB structures25
InterPro domains10
Orthologs4 model organisms
ClinVar variants827 total
Pathogenic variants66
Likely pathogenic50
SpliceAI predictions2,303
AlphaMissense predictions4,516
Reactome pathways11
GO annotations72
STRING interactions2,404
IntAct interactions88
TF target genes246+
JASPAR motifs2
Disease associations16 (GenCC)
HPO phenotypes254
GWAS associations31
Expression conditions283 (207 present)
Single-cell datasets6

╔══════════════════════════════════════════════════════════════════════════════╗ ║ END OF TP63 REFERENCE ║ ║ Generated via BioBTree Database Queries ║ ╚══════════════════════════════════════════════════════════════════════════════╝ I’ve compiled a comprehensive cross-database identifier and functional mapping reference for human TP63 (tumor protein p63). Key Highlights TP63 is a critical transcription factor in the p53 family with:

  • Gene location: Chromosome 3q28 (189,631,389-189,897,276, + strand)

  • 14 transcripts (12 protein-coding), with NM_003722.5 as MANE Select

  • 680 amino acid canonical protein (Q9H3D4)

  • 25 experimental structures in PDB

  • 827 clinical variants (66 pathogenic, 50 likely pathogenic)

  • 2,404 protein interactions (STRING)

  • 246+ transcriptional targets as a transcription factor Major disease associations:

  • EEC syndrome (ectrodactyly-ectodermal dysplasia-clefting)

  • ADULT syndrome

  • Limb-mammary syndrome

  • Rapp-Hodgkin syndrome

  • Strong GWAS links to lung cancer, bladder cancer, and squamous cell carcinomas Expression pattern: Highly expressed in stratified epithelia (skin, oral mucosa, esophagus, cervix), consistent with its essential role in epithelial development and maintenance.